$8.94 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$148 ThousandTotal revenue in the last quarter.
-$92.4 MillionNet income is all revenues minus all expenses including taxes and interest in the last quarter.
-$5.29Earnings per share is the amount of net income that is attributed to each single share outstanding.
$0.00 (0.0%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
-25.63xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$-92.4 MillionEarnings before interest expenses and taxes in the last quarter.
0The number of full time employees.
CRISPR Therapeutics (NASDAQ: CRSP) is a biotechnology company that is developing therapeutics using a new and innovative methodology. CRISPR Therapeutics is named after a genetic editing technique ...Securities, 2 months ago
CRISPR Therapeutics (NASDAQ:CRSP) posted its quarterly earnings results on Monday. The company reported ($1.50) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($1.27) by ($...Transcript Daily, 2 months ago
Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the DayYahoo Finance UK, 2 months ago